傳媒專區
傳媒專區 > 媒體報導 > Lung cancer sufferers who don't smoke find help

Lung cancer sufferers who don't smoke find help

12-09-2014

 Lung cancer sufferers who don't smoke find help

Friday, September 12, 2014

The newly established ALK Lung Cancer Caring Group is advocating more help and attention for struggling patients.

The most effective treatment for anaplastic lymphoma kinase lung cancer is said to be targeted medication. However, such an approach comes at a high cost, ranging from HK$35,000 to HK$60,000 a month, for most patients.

ALK sufferers are usually non-smokers, with the lung cancer believed to be genetic.

Additionally, the group stresses that most patients require a lot of emotional support and counseling.

The median age for diagnosed ALK patients is 48.5 years, and coming down with cancer at that age affects their careers as well as family life. For example, a fourth-stage female patient, surnamed Chan, experienced huge financial and psychological burdens.

She suffered a great deal of stress and emotional trauma as a result of her illness. "Before seeking support from cancer groups, I was always depressed because I had the disease despite not being a smoker or drinker.""I could not afford targeted medication until recently because it is so expensive. The cost alone would exceed my salary, let alone my daily expenses," said Chan, who is 32 years old.

Patricia Poon Chu-mun, specialist in clinical oncology, said lung cancer due to genetic mutation often occurs in younger, non- smokers.

She said the median age for lung cancer sufferers is 66 and more than 90 percent of ALK patients are non-smokers.

BRIAN WONG

www.thestandard.com.hk/news_detail.asp

疑難排解

會員註冊


或許你會想看
【有誰共鳴】嘉賓:黃麗珊醫生
【有誰共鳴】這個腫瘤科醫生不太冷 今個星期,我們邀請到 臨床腫瘤科專科醫生 – 黃麗珊醫生 (Dr. Cind […]
推動抗癌資訊普及與社群交流:癌症資訊網見證恒瑞醫藥落戶香港
【推動抗癌資訊普及與社群交流:癌症資訊網見證恒瑞醫藥落戶香港】 上周五,癌症資訊網應邀出席恒瑞醫藥(Hengr […]
養和成為亞洲首個光子計數電腦掃描模擬定位技術卓越示範中心
養和成為亞洲首個光子計數電腦掃描模擬定位技術卓越示範中心 與西門子醫療攜手推進全球精準醫療及醫學造影水平 (2 […]
【有誰共鳴】嘉賓:Ritchie Kwok
一位藥劑師的人生告白。 今天腫瘤科專科藥劑師 郭靜芝女士 (Ritchie Kwok) 已在《有誰共鳴》中,打 […]
醫院管理局研討大會2026
今天,醫院管理局研討大會2026隆重開幕。作為一年一度香港醫療界的重要盛事,今年更別具意義。 癌症資訊網慈善基 […]
生命教育 – 從校園開始
多年以來,我們持續與本地學校合作,舉辦生命教育、健康意識分享活動。這不僅是一項社區服務,更是一項關乎預防、韌性 […]
【大學研究】使用輔助及另類療法或會降低乳癌存活機會
使用輔助及另類療法或會降低乳癌存活機會 早期乳房造影篩查的進步以及新一代標靶治療,降低了乳腺癌的整體死亡率和復 […]
【ALK 肺癌治療新突破:病人故事與醫生分享】李兆澄醫生
2026年4月28日 今天,我的好朋友Jennifer,一位ALK肺癌患者,再一次和我們分享她的治療旅程。 ( […]
【活動花絮】攜手同行,一步一溫暖
今天癌症資訊網與 DeeDa 水滴籌(香港) 一起,參與善寧會第33屆「登山善行2026」! 在陽光灑落的大潭 […]
【晚期癌症】新型免疫治療已成國際標準 促請盡快擴大醫管局藥物名冊及安全網資助
晚期癌症治療面臨新挑戰: 新型免疫治療已成國際標準 促請盡快擴大醫管局藥物名冊及安全網資助 【2026年4月2 […]
港大醫學院揭示癌症藥物抗藥性關鍵機制
2026年4月27日 香港大學李嘉誠醫學院(港大醫學院)生物醫學學院研究團隊發現,癌症病人對廣泛使用的癌症藥物 […]
生活方式醫學與癌症存活照護(二):身體活動——從每一步開始重建力量
生活方式醫學與癌症存活照護(二):身體活動——從每一步開始重建力量 文: 竹村奈緒美教授 在上期專欄中,我們介 […]